October 07, 2026 09:07 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
RBI shocks borrowers with first repo rate hike since 2023; rates raised to 5.50% | ‘Completely false’: Virat Kohli reacts to ₹5 crore claim over Premanand Maharaj visit | We’re watching it very closely: US urges Russia to share more information on plague situation | This isn’t about schools: Trump blames ‘mass migration’ and Islam for violent protests across France | ‘Crash axe’ blow fractured Smit Machchhar’s skull: Shocking details emerge from flydubai cockpit horror | ‘Vote thief’ Gyanesh Kumar: Rahul Gandhi climbs barricade, waves Tricolour during explosive INDIA bloc protest | ‘Crash axe’ blow fractured Smit Machchhar’s skull: Shocking details emerge from flydubai cockpit horror | ‘He should not have been flying’: JD Vance on Flydubai co-pilot | Israel was ready to shoot down Flydubai jet if it kept flying towards Tel Aviv: Reports | 'If law wasn't followed, we can undo it': Supreme Court's big warning on SIR process amid Gyanesh Kumar row
Covidd-19 Vaccine

Vaccine by the end of 2020 possible, says Union health minister

| @indiablooms | Aug 31, 2020, at 10:47 pm

New Delhi/IBNS: Union health and family welfare minister Dr Harshvardhan said on Monday that a vaccine might be ready in the country by the end of this year, said media report.

The minister said India is not lagging behind anyone else in the world in efforts to contribute towards the development of a coronavirus vaccine.

There are 7-8 vaccine candidates, three of them in the clinical trial phase and the rest in the pre-clinical phase, he informed.

Currently, two vaccine candidates developed in India — Covaxin by Bharat Biotech and ZyCoV-D by Zydus Cadila are in the midst of phase II clinical trial, while Covishield by the University of Oxford has recently started the phase II clinical trial in India.

Vaccine manufacturer AstraZeneca has entered into an agreement with Serum Institute of India to manufacture Oxford's COVID-19 vaccine candidate for India and countries in the low-income group.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.